Describing intravenous extravasation in children (DIVE study)

Canadian Journal of Hospital Pharmacy

Volumn 64, Issue 5, 2011, Pages 340-345

  Paquette, Vanessa ^a,b   McGloin, Rumi ^a,b   Northway, Tracie ^a   DeZorzi, Pia ^a   Singh, Avash ^a,b   Carr, Roxane ^a,b  

^a CHILDREN S AND WOMEN S HEALTH CENTRE OF BRITISH COLUMBIA   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Extravasation; Hyaluronidase; IV medications; Pediatrics

Indexed keywords

ADRENALIN; ALBUMIN; AMPICILLIN; ANTIBIOTIC AGENT; ANTIDOTE; BICARBONATE; CALCIUM CHLORIDE; CEPHALOSPORIN; CLOXACILLIN; FUROSEMIDE; GLUCOSE; HYALURONIDASE; IMMUNOGLOBULIN; LORAZEPAM; MORPHINE; PHENTOLAMINE; PHENYTOIN; POTASSIUM CHLORIDE; VANCOMYCIN;

ABSENCE OF SIDE EFFECTS; ADOLESCENT; ADULT; ARTICLE; CENTRAL VENOUS CATHETER; CHILD; CLINICAL ARTICLE; DRUG EFFICACY; DRUG SAFETY; EMERGENCY WARD; EXTRAVASATION; FEMALE; HUMAN; INCIDENCE; INFANT; INTENSIVE CARE UNIT; INTRAVENOUS ADMINISTRATION; MALE; PEDIATRIC WARD; PRESCHOOL CHILD; SCHOOL CHILD; SURGICAL WARD; TERTIARY HEALTH CARE; TOTAL PARENTERAL NUTRITION; TREATMENT OUTCOME;

EID: 84880047225     PISSN: 00084123     EISSN: 19202903     Source Type: Journal    
DOI: 10.4212/cjhp.v64i5.1069     Document Type: Article

References (11)

1. Kumar RJ, Pegg SP, Kimble RM. Management of extravasation injuries. ANZ J Surg 2001;71(5): 285-289.
2. Camp-Sorrell D. Developing extravasation protocols and monitoring outcomes. J Intraven Nurs 1998;21(4): 232-239. (Pubitemid 28347533)
3. Cartlidge PHT, Fox PE, Rutter N. The scars of newborn intensive care. Early Hum Dev 1990;21(1): 1-10. (Pubitemid 20037845)
4. Wilkins CE, Emmerson AJB. Extravasation injuries on regional neonatal units. Arch Dis Child Fetal Neonatal Ed 2004;89(3):F274-F275. (Pubitemid 38570162)
5. Treatment of medication extravasation. In: Clinical standards manual. Minneapolis/St Paul (MN): Children's Hospitals and Clinics; 2004.
6. Tong R. Preventing extravasation injuries in neonates. Pediatr Nurs 2007; 19(8): 22-25.
7. Extravasation of chemotherapy, prevention and management of. Policy III-20. Vancouver (BC): British Columbia Cancer Agency, Provincial Systemic Program Committee; 1997 [cited 2008 Oct 14]. Available from: www.bccancer.bc.ca/HPI/ChemotherapyProtocols/Policies.htm
8. Mader I, Furst-Weger PR, Mader RM, Negler-Semenitz E, Wassertheurer S, editors. Extravasation of cytotoxic drugs: compendium for prevention and treatment. 2nd ed. New York (NY): Springer; 2009.
9. Yosowitz P, Ekland DA, Shaw CR, Parsons RW. Peripheral intravenous infiltration necrosis. Ann Surg 1975;182(5): 553-556.
10. Mouridsen HT, Langer SW, Buter J, Eidtmann H, Rosti G, de Wit M, et al. Treatment of anthracycline extravasation with Savene (dexrazoxane): results from two prospective clinical multicentre studies. Ann Oncol 2007;18(3): 546-550. (Pubitemid 46359637)
11. Bertelli G, Gozza A, Forno GB, Vidili MG, Silvestro S, Venturini M, et al. Topical dimethylsulfoxide for the prevention of soft tissue injury after extravasation of vesicant cytotoxic drugs: a prospective clinical study. J Clin Oncol 1995;13(11): 2851-2855.